MARKET

ABCM

ABCM

Abcam Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.46
+0.09
+0.63%
Pre Market: 14.18 -0.28 -1.94% 07:01 07/01 EDT
OPEN
14.16
PREV CLOSE
14.37
HIGH
14.49
LOW
14.10
VOLUME
400
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
12.54
MARKET CAP
3.31B
P/E (TTM)
628.70
1D
5D
1M
3M
1Y
5Y
Abcam: Appointment of Vice President of Investor Relations
Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations.
PR Newswire · 4d ago
Abcam plc's (LON:ABC) Intrinsic Value Is Potentially 43% Above Its Share Price
Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by taking the expected...
Simply Wall St. · 06/18 08:24
Are Abcam plc's (LON:ABC) Mixed Financials Driving The Negative Sentiment?
Abcam (LON:ABC) has had a rough month with its share price down 11%. It is possible that the markets have ignored the...
Simply Wall St. · 05/02 09:35
Abcam the most awarded company at 2022 industry awards
Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial inves...
PR Newswire · 03/25 12:40
Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Abcam PLC Sponsored ADR (ABCM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions ...
Zacks · 03/18 14:00
Sector Update: Health Care Advancing to Begin New Week
MT Newswires · 03/14 15:59
Sector Update: Health Care Stocks Helping Limit Broader Market Declines
MT Newswires · 03/14 13:34
Abcam ADS reports FY results
Abcam press release (NASDAQ:ABCM): 12M net income of £47.2M Revenue of £315.4M (+17.1% Y/Y).
Seekingalpha · 03/14 12:11
More
No Data
Learn about the latest financial forecast of ABCM. Analyze the recent business situations of Abcam Plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
0.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ABCM stock price target is 20.85 with a high estimate of 24.82 and a low estimate of 17.87.
High24.82
Average20.85
Low17.87
Current 14.46
EPS
Actual
Estimate
-0.020.040.100.15
2020/12
2020/06
2021/12
2021/06
2022/12
Institutional Holdings
Institutions: 66
Institutional Holdings: 24.82M
% Owned: 10.84%
Shares Outstanding: 228.95M
TypeInstitutionsShares
Increased
35
1.56M
New
14
498.37K
Decreased
10
2.10M
Sold Out
5
764.80K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.21%
Pharmaceuticals & Medical Research
-0.21%
Key Executives
Chief Executive Officer/Executive Director
Alan Hirzel
Chief Financial Officer/Executive Director
Michael Baldock
General Counsel/Secretary
Marc Perkins
Non-Executive Independent Director
Mara Aspinall
Non-Executive Independent Director
Mark Capone
Non-Executive Independent Director
Sally Crawford
Non-Executive Independent Director
Giles Kerr
Non-Executive Independent Director
Chienling Lee
No Data
No Data
About ABCM
Abcam plc is a global life sciences company. The Company is focused on identifying, developing and distributing reagents and tools which are required in the fields of life science research. The Company's product offering includes portfolio of antibodies and related protein research tools that are fundamental to its customers' research and experimental workflow. The Company's product type includes primary antibodies, secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selector, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers. The Company's products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The Company serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.

Webull offers kinds of Abcam PLC (ADR) stock information, including NASDAQ:ABCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABCM stock methods without spending real money on the virtual paper trading platform.